The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Bikbavova G.R.

Omsk State Medical University

Livzan M.A.

Omsk State Medical University

Morova N.A.

Omsk State Medical University

Lisyutenko N.S.

Omsk State Medical University

Romanyuk A.E.

Omsk State Medical University

Tret’yakova T.V.

Regional Clinical Hospital

Relationship between endothelial dysfunction and systemic inflammation in ulcerative colitis patients

Authors:

Bikbavova G.R., Livzan M.A., Morova N.A., Lisyutenko N.S., Romanyuk A.E., Tret’yakova T.V.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2024;27(7): 85‑93

Read: 841 times


To cite this article:

Bikbavova GR, Livzan MA, Morova NA, Lisyutenko NS, Romanyuk AE, Tret’yakova TV. Relationship between endothelial dysfunction and systemic inflammation in ulcerative colitis patients. Russian Journal of Preventive Medicine. 2024;27(7):85‑93. (In Russ.)
https://doi.org/10.17116/profmed20242707185

References:

  1. Shelygin YuA, Ivashkin VT, Belousova EA, et al. Ulcerative colitis (K51), adults. Koloproktologia. 2023;22(1):10-44. (In Russ.). https://doi.org/10.33878/2073-7556-2023-22-1-10-44
  2. Borowitz SM. The epidemiology of inflammatory bowel disease: Clues to pathogenesis? Frontiers in Pediatrics. 2023;10:1103713. https://doi.org/10.3389/fped.2022.1103713
  3. Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology. 2021;160:1570-1583. https://doi.org/10.1053/j.gastro.2020.12.031
  4. Theofilis P, Sagris M, Oikonomou E, et al. Inflammatory mechanisms contributing to endothelial dysfunction. Biomedicines. 2021;9(7):781.  https://doi.org/10.3390/biomedicines9070781
  5. Xu S, Ilyas I, Little PJ, al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacological Reviews. 2021;73(3):924-967.  https://doi.org/10.1124/pharmrev.120.000096
  6. Gallo G, Volpe M, Savoia C. Endothelial dysfunction in hypertension: current concepts and clinical implications. Frontiers in Medicine. 2022;8:798958. https://doi.org/10.3389/fmed.2021.798958
  7. Roumeliotis S, Mallamaci F, Zoccali C. Endothelial dysfunction in chronic kidney disease, from biology to clinical outcomes: a 2020 update. Journal of Clinical Medicine. 2020;9(8):2359. https://doi.org/10.3390/jcm9082359
  8. Scioli MG, Storti G, D’Amico F, et al. Oxidative stress and new pathogenetic mechanisms in endothelial dysfunction: potential diagnostic biomarkers and therapeutic targets. Journal of Clinical Medicine. 2020;9(6):1995. https://doi.org/10.3390/jcm9061995
  9. Wu H, Xu M, Hao H, et al. Endothelial dysfunction and arterial stiffness in patients with inflammatory bowel disease: a systematic review and meta-analysis. Journal of Clinical Medicine. 2022;11(11):31797. https://doi.org/10.3390/jcm11113179
  10. Ray A, Maharana K C, Meenakshi S, Singh S. Endothelial dysfunction and its relation in different disorders: Recent update. Health Sciences Review. 2023:100084. https://doi.org/10.1016/j.hsr.2023.100084
  11. Iazvennyi kolit. Klinicheskie rekomendatsii. 2022. Odobreno Nauchno-prakticheskim Sovetom Ministerstva zdravooxraneniya Rossijskoj Federacii. Accessed January 30, 2024. (In Russ.). https://cr.minzdrav.gov.ru/schema/193_1#doc_b
  12. Ivanov AN, Grechikhin AA, Norkin IA, Puchinyan DM. Methods of endothelial dysfunction diagnosis. Regionarnoe krovoobrashhenie i mikrocirkuljacija. 2014;13(4):4-11. (In Russ.).
  13. Martynov AI, Avetyak NG, Akatova EV, et al. Endothelial dysfunction and methods for its diagnostics. Rossijskij kardiologicheskij zhurnal. 2005;(4): 94-98. (In Russ.).
  14. Biondi RB, Salmazo PS, Bazan SGZ, et al. Cardiovascular risk in individuals with inflammatory bowel disease. Clinical and Experimental Gastroenterology. 2020;13:107-113.  https://doi.org/10.2147/CEG.S243478
  15. Cibor D, Domagala-Rodacka R, Rodacki T, et al. Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications. World Journal of Gastroenterology. 2016;22(3):1067-1077. https://doi.org/10.3748/wjg.v22.i3.1067
  16. Ferreira-Duarte M, Sousa JB, Diniz C, et al. Experimental and clinical evidence of endothelial dysfunction in inflammatory bowel disease. Current Pharmaceutical Design. 2020;26(30):3733-3747. https://doi.org/10.2174/1381612826666200701212414
  17. Steyers CM 3rd, Miller FJ Jr. Endothelial dysfunction in chronic inflammatory diseases. International Journal of Molecular Sciences. 2014;15(7):11324-11349. https://doi.org/10.3390/ijms150711324
  18. Arijs I, De Hertogh G, Machiels K, et al. Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment. The American Journal of Gastroenterology. 2011;106(4):748-761.  https://doi.org/10.1038/ajg.2011.27
  19. Chen H, Li W, Hu J, et al. Association of serum lipids with inflammatory bowel disease: a systematic review and meta-analysis. Frontiers in Medicine. 2023;10:1198988. https://doi.org/10.3389/fmed.2023.1198988
  20. Lykowska-Szuber L, Rychter AM, Dudek M, et al. What links an increased cardiovascular risk and inflammatory bowel disease? a narrative review. Nutrients. 2021;13(8):2661. https://doi.org/10.3390/nu13082661
  21. Bicbavova GR, Drapkina OM, Livzan MA, et al. Cardiovascular risk factors in patients with ulcerative colitis Terapevticheskii arkhiv. 2023;95(8):658-663. (In Russ.). https://doi.org/10.26442/00403660.2023.08.202338
  22. Soh H, Im JP, Han K, et al. Crohn’s disease and ulcerative colitis are associated with different lipid profile disorders: a nationwide population-based study. Alimentary Pharmacology and Therapeutics. 2020;51(4):446-456.  https://doi.org/10.1111/apt.15562
  23. D’Ascenzo F, Bruno F, Iannaccone M, et al. Patients with inflammatory bowel disease are at increased risk of atherothrombotic disease: A systematic review with meta-analysis. International Journal of Cardiology. 2023;378: 96-104.  https://doi.org/10.1016/j.ijcard.2023.02.042
  24. Jaiswal V, Batra N, Dagar M, et al. Inflammatory bowel disease and associated cardiovascular disease outcomes: A systematic review. Medicine. 2023; 102(6):e32775. https://doi.org/10.1097/MD.0000000000032775
  25. Olivera PA, Zuily S, Kotze PG, et al. International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease. Nature reviews. Gastroenterology and Hepatology. 2021;18(12): 857-873.  https://doi.org/10.1038/s41575-021-00492-8
  26. Bernstein CN, Wajda A, Blanchard JF. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clinical Gastroenterology and Hepatology. 2008;6(1):41-45.  https://doi.org/10.1016/j.cgh.2007.09.016
  27. Li Z, Qiao L, Yun X, et al. Increased risk of ischemic heart disease and diabetes in inflammatory bowel disease. Zeitschrift fur Gastroenterologie. 2021; 59(2):117-124.  https://doi.org/10.1055/a-1283-6966
  28. Vavlukis M, Vavlukis A. Inflammation and endothelial dysfunction common mechanisms of inflammatory bowel diseases and cardiovascular disease. EC Gastroenterology and Digestive System. 2019;6(9):828-831. 
  29. Grundy SM, Stone NJ, Bailey AL, et al. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA. Guideline on the management of blood cholesterol: a report of the American College of Cardiology. American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1082-e1143. https://doi.org/10.1161/CIR.0000000000000625
  30. Wang A, Liu J, Li C, et al. Cumulative exposure to high-sensitivity C-reactive protein predicts the risk of cardiovascular disease. Journal of the American Heart Association. 2017;6(10):e005610. https://doi.org/10.1161/JAHA.117.005610
  31. Stanojevic NB, Ivanović ZJ, Djurovic S, et al. Lack of association between low HDL-cholesterol and elevated circulating cellular adhesion molecules in normolipidemic CAD patients and healthy subjects. International Heart Journal. 2005;46(4):593-600.  https://doi.org/10.1536/ihj.46.593

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.